Drägerwerk AG & Co. Kgaa: Dräger Presents Ambition 2030: EUR 4.5 Billion In Net Sales And A 10 To 12 Percent EBIT Margin
|
Drägerwerk AG & Co. KGaA
/ Key word(s): Capital Markets Day
Drägerwerk AG & Co. KGaA: Dräger presents Ambition 2030: EUR 4.5 billion in net sales and a 10 to 12 percent EBIT margin 18.11.2026 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. Dräger presents Ambition 2030: EUR 4.5 billion in net sales and a 10 to 12 percent EBIT margin
The medical division plans to continue improving acute care. To this end, its strong position in life-sustaining systems will be expanded. Further growth will come from integrated solutions and recurring revenues from the installed base of equipment. Patient monitoring will also be expanded. Regionally, the medical division is focusing in particular on growth in the U.S. and Asia-Pacific. Europe remains a strong base. Net sales growth and efficiency measures are expected to increase profitability. By 2030, the medical division is targeting net sales of around EUR 2.5 billion and an EBIT margin of 7 to 9 percent. Targeted scaling in the safety division's focus markets The safety division aims to scale profitable growth in a targeted manner. The focus is on four growth markets: U.S. fire departments, defense, maritime applications as well as energy transition and cleantech. Technology and innovation are intended to strengthen the offering. The plan also includes expanding market access in the U.S. and the Asia-Pacific region and leveraging Europe as a strong base. Further growth in net sales and higher productivity are intended to support profitability. By 2030, the division is aiming at net sales of around EUR 2.0 billion and an EBIT margin of 14 to 16 percent. Strong balance sheet, disciplined capital allocation, and attractive dividend The improvement in margins is expected to result from a higher gross margin and a below-proportionate increase in functional expenses. To this end, Dräger intends, among other things, to improve pricing, optimize direct costs, and increase productivity. More efficient development processes and improvements in sales and administration are expected to make further contributions. At the same time, Dräger wants to safeguard its strong balance sheet and high equity ratio. In capital allocation, financial stability and high-return organic investments take priority. Selective acquisitions can complement the strategy. The dividend policy remains attractive. Dräger intends to continue distributing at least 30 percent of net profit to its shareholders. This would lead to double-digit dividend growth in the coming years. Sustainability supports Ambition 2030 The sustainability strategy is also an important part of Ambition 2030. Dräger's goal is to reduce Scope 1 and Scope 2 emissions by more than 30 percent by 2030 compared to the base year of 2024 and to achieve“net zero” by 2045. Dräger also wants to help its customers reduce environmental impacts and operating costs with resource-efficient products and solutions. This customer benefit is intended to strengthen the Company's market position and open up additional growth opportunities. The combination of sustainability and profitability supports Ambition 2030. Live broadcast of the Capital Markets Day The Capital Markets Day will be broadcast live from 10:15 a.m. to approximately 2:30 p.m. and can be viewed online via Dräger's Investor Relations website. A recording of the event and the Executive Board presentations will be made available afterward on the Company's Investor Relations website ( ). Further information is available at . Disclaimer This press release contains statements on the future development of Dräger Group. These forward-looking statements are based on the current expectations, presumptions, and forecasts of the Executive Board as well as the information available to date. They were compiled to the best of the company's knowledge. Dräger does not provide any warranty nor assume any responsibility for the future developments and results described above. These are dependent on a number of factors. They entail various risks and contingencies outside of the company's influence and are based on assumptions which could prove to be incorrect. Dräger does not assume any responsibility for updating the forward-looking statements contained in this release. This does not infringe any legal stipulations on the adjustment of forecasts. Information on the financial indicators used (incl. alternative performance measures) can be found on our corporate website in our Investor Relations section. 18.11.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Drägerwerk AG & Co. KGaA |
| Moislinger Allee 53-55 | |
| 23558 Lübeck | |
| Germany | |
| Phone: | +49 (0)451 882-0 |
| Fax: | +49 (0)451 882-2080 |
| E-mail: | ... |
| Internet: | |
| ISIN: | DE0005550602, DE0005550636 (Vorzugsaktien) |
| WKN: | 555060, 555063 (Vorzugsaktien) |
| Indices: | SDAX, TecDax |
| Listed: | Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Hamburg, Hanover, Munich, Stuttgart, Tradegate BSX; London, Aquis, Stockholm, BX, SIX, Vienna Stock Exchange |
| LEI Code: | 5493005UFVHY0PPNKD75 |
| EQS News ID: | 2436204 |
| End of News | EQS News Service |
2436204 18.11.2026 CET/CEST
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.

Comments
No comment